-
-
-
-
-
-
-
AngioDynamics gains European approval for NanoKnife tumor treatment
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on AngioDynamics (ANGO)
-
-
-
-
-
-
-
AngioDynamics (ANGO) Tops Q3 EPS by 14c ; Offers Guidance
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on AngioDynamics (ANGO)
-
-
-
-
-
-
-
AngioDynamics (ANGO) Tops Q4 EPS by 11c, provides guidance
416,806 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

